Vertex has recorded some 25,000 prescriptions for Journavx since its January approval and is in the process of getting big ...

Niu worked with University of Pennsylvania physicist Randall D. Kamien and Geneviève Dion, founding director of Drexel ...

Vertex said its profit fell due to higher operating expenses and a $379 million intangible asset impairment charge associated with treatment for Type 1 diabetes patients, which the company said in ...

Q1 2025 Management View CEO Reshma Kewalramani highlighted $2.77 billion in revenue for Q1 2025, reflecting 3% growth ...